Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AC006378.2 (ENSG00000278959) is annotated as an uncharacterized or novel transcript, likely non-coding, with no established protein product, biological function, or disease relevance. It is not recognized as a canonical therapeutic target, and there is high ambiguity in its nomenclature and annotation. No drugs, mechanisms of action, or biomarkers are associated with this target. Given its apparent lack of functional or therapeutic evidence and confusion with the TEC gene, it should not be considered a valid or correct therapeutic target in drug discovery or biomedical classification[3]. If more structured or validated information emerges linking this entry to a characterized gene or disease role, its classification and relevance may require re-evaluation. As of current data, it appears to be a non-protein-coding, non-therapeutic, and possibly incorrectly referenced entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AC006378.2 (ENSG00000278959).